Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
Adrienne Waks, MD
PeerDato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Ben Park, MD, PhD
PeerRachelle W. Johnson, PhD
PeerConstance Lehman, MD, PhD
Peer